Who is leaving CVS Health?

Helena B. Foulkes, Executive Vice President of CVS Health Corporation and President of CVS Pharmacy, is leaving the company.

When is Helena B. Foulkes' departure effective?

Her departure is effective February 9, 2018.

What was Helena B. Foulkes' role at CVS Health?

She served as Executive Vice President and President of CVS Pharmacy, a key retail division of the company.

Is this departure expected to have a significant impact on CVS Health?

While the immediate impact is not detailed, a departure of a division president can signal changes in strategy or operations. Investors should watch for any follow-up announcements regarding her successor and the future direction of the CVS Pharmacy segment.

CVS 8-K: Leadership Changes

Summary

This 8-K filing from CVS Health Corporation (CVS) on February 5, 2018, announces a significant executive departure. Helena B. Foulkes, who held the position of Executive Vice President and President of CVS Pharmacy, will be leaving the company effective February 9, 2018. This departure represents a change in leadership within a key operational segment of the company.

Key Highlights

1Helena B. Foulkes, EVP and President of CVS Pharmacy, is departing CVS Health.
2Her departure is effective February 9, 2018.
3The filing specifically notes her role as President of CVS Pharmacy, indicating a leadership change in a core business segment.
4This announcement falls under Item 5.02 of the 8-K, concerning departures of officers.
5Investors should monitor future filings for information on her replacement and any potential strategic shifts related to the CVS Pharmacy division.

CVS HEALTH Corp 8-K Report, Executive Changes (Feb 6, 2018)

Summary

Key Highlights

Frequently Asked Questions